Skip to content

Oocyte Cryopreservation by Slow Freezing and Vitrification

Longitudinal Evaluation of Vitrification of Human Oocytes

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01223105
Enrollment
2
Registered
2010-10-18
Start date
2009-07-31
Completion date
2010-07-31
Last updated
2013-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women Diagnosed With Cancer, Egg Donors, Single Women, Failed Sperm Procurement in IVF

Keywords

slow freeze, cryopreservation, vitrification, oocyte preservation

Brief summary

This study seeks to evaluate whether the vitrification technique, as compared to the more traditional slow-cooling technique, leads to higher rates of successful thawing, fertilization, implantation and delivery.

Detailed description

Cryopreservation (freezing) of human gametes (unfertilized egg) provides a great potential to preserve or extend fertility in the face of disease and social circumstances (cancer diagnosis, delaying childbirth, single women, etc.). There are two methods for storage of oocytes (unfertilized eggs): slow freezing or vitrification (uses higher concentrations of cryoprotectant and faster cooling rates). Slow freezing is the standard method and has been successful for embryos since 1983 and more recently for oocytes. Recent reports indicate that vitrification may be more successful than slow freezing. The aim of this study is to examine the rate at which frozen eggs survive freezing and thawing, the rate at which the frozen/thawed eggs fertilize with sperm and the pregnancy outcomes of oocyte (egg) vitrification cycles to determine whether the outcomes are similar or better than standard oocyte (egg) cryopreservation (freezing) cycles.

Interventions

PROCEDUREslow freeze

Eggs will be placed in a cryo-protected solution and frozen slowly in a programable freezer

PROCEDUREVitrification

Eggs will be placed in a high concentration of cryo-protectant and frozen very quickly by plunging in liquid nitrogen

Sponsors

Reproductive Medicine Associates of New Jersey
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 21 and 50 years, at the time of informed consent. * Subjects must agree to undergo intracytoplasmic sperm injection (ICSI)

Exclusion criteria

* Presence of any medical condition that contraindicates ovarian stimulation, in vitro fertilization or pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Oocytes survival after thaw1 monthWhether each oocyte survives the thawing process

Secondary

MeasureTime frameDescription
Fertilization1 monthWhether each oocyte is successfully fertilized
Implantation1 monthWhether pregnancy occurs.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026